Organised by the European Organisation for Research and Treatment of Cancer (EORTC), the National Cancer Institute (NCI), and the American Association for Cancer Research (AACR), the 2026 Symposium gathers leading academics, scientists, and pharmaceutical industry experts from around the world. This event serves as a platform to explore groundbreaking advancements in drug development, refine target selection strategies, and assess the influence of new molecular biology discoveries.
